Aurobindo Pharma's dividends per share for the
three
months ended in Mar. 2024 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Its Dividend Payout Ratio for the
three
months ended in Mar. 2024 was 0.00. As of today, Aurobindo Pharma's Dividend Yield % is 0.00%.
During the past 12 months, Aurobindo Pharma's average Dividends Per Share Growth Rate was -40.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 4.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 18.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 15.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Aurobindo Pharma was 132.10% per year. The lowest was -16.40% per year. And the median was 18.50% per year.
For more information regarding to dividend, please check our Dividend Page.
Aurobindo Pharma Dividends per Share Historical Data
The historical data trend for Aurobindo Pharma's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aurobindo Pharma's Dividends per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurobindo Pharma's Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Aurobindo Pharma's Dividend Yield % falls into.
Aurobindo Pharma Dividends per Share Calculation
Dividends paid to per common share.
Aurobindo Pharma (GREY:ARBQY) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Aurobindo Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Aurobindo Pharma was 0.23. The lowest was 0.05. And the median was 0.08.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of Aurobindo Pharma was 1.74%. The lowest was 0.23%. And the median was 0.41%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurobindo Pharma Dividends per Share Related Terms
Thank you for viewing the detailed overview of Aurobindo Pharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Aurobindo Pharma (Aurobindo Pharma) Business Description
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARBQY has been successfully added to your 